Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emanuela Martinuzzi

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Diabetes|February 29, 2008
The frequency and immunodominance of islet-specific CD8+ T-cell responses change after type 1 diabetes diagnosis and treatmentEmanuela Martinuzzi, Giulia Novelli, Matthieu Scotto, et al.
BMC Neurology|April 17, 2020
Reduced serum levels of pro-inflammatory chemokines in fragile X syndromeAnke Van Dijck, Susana Barbosa, Patricia Bermudez-Martin, et al.
Diabetes|March 1, 2007
CD8+ T-cell responses identify beta-cell autoimmunity in human type 1 diabetesRoberto Mallone, Emanuela Martinuzzi, Philippe Blancou, et al.
Blood|July 1, 2011
acDCs enhance human antigen-specific T-cell responsesEmanuela Martinuzzi, Georgia Afonso, Marie-Claude Gagnerault, et al.
Clinical and Experimental Rheumatology|May 30, 2012
Expression of NKG2D and CD107 in CD8(+) effector memory lymphocytes in Churg-Strauss syndromeMonica Boita, Giovanni Rolla, Roberto Mallone, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 22, 2007
Immunization of HLA class I transgenic mice identifies autoantigenic epitopes eliciting dominant responses in type 1 diabetes patientsPhilippe Blancou, Roberto Mallone, Emanuela Martinuzzi, et al.
International Immunology|May 13, 2008
Alloreactivity and anti-tumor activity segregate within two distinct subsets of cytokine-induced killer (CIK) cells: implications for their infusion across major HLA barriersDario Sangiolo, Emanuela Martinuzzi, Maja Todorovic, et al.
Annals of Clinical and Translational Neurology|October 8, 2025
Interleukin-6 as a Key Biomarker in Facioscapulohumeral Dystrophy: Evidence From Longitudinal AnalysesJonathan Pini, Emanuela Martinuzzi, Sandra Dhifallah, et al.
Viruses|March 26, 2022
Low T Cell Responsiveness in the Early Phase of COVID-19 Associates with Progression to Severe Pneumonia in Kidney Transplant RecipientsMarion Cremoni, Sébastien Cuozzo, Emanuela Martinuzzi, et al.
Neuro-Oncology|May 18, 2012
Three sensitive assays do not provide evidence for circulating HuD-specific T cells in the blood of patients with paraneoplastic neurological syndromes with anti-Hu antibodiesAdriaan H C de Jongste, Marieke T de Graaf, Emanuela Martinuzzi, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Diabetes|February 29, 2008
The frequency and immunodominance of islet-specific CD8+ T-cell responses change after type 1 diabetes diagnosis and treatmentEmanuela Martinuzzi, Giulia Novelli, Matthieu Scotto, et al.
BMC Neurology|April 17, 2020
Reduced serum levels of pro-inflammatory chemokines in fragile X syndromeAnke Van Dijck, Susana Barbosa, Patricia Bermudez-Martin, et al.
Diabetes|March 1, 2007
CD8+ T-cell responses identify beta-cell autoimmunity in human type 1 diabetesRoberto Mallone, Emanuela Martinuzzi, Philippe Blancou, et al.
Blood|July 1, 2011
acDCs enhance human antigen-specific T-cell responsesEmanuela Martinuzzi, Georgia Afonso, Marie-Claude Gagnerault, et al.
Clinical and Experimental Rheumatology|May 30, 2012
Expression of NKG2D and CD107 in CD8(+) effector memory lymphocytes in Churg-Strauss syndromeMonica Boita, Giovanni Rolla, Roberto Mallone, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 22, 2007
Immunization of HLA class I transgenic mice identifies autoantigenic epitopes eliciting dominant responses in type 1 diabetes patientsPhilippe Blancou, Roberto Mallone, Emanuela Martinuzzi, et al.
International Immunology|May 13, 2008
Alloreactivity and anti-tumor activity segregate within two distinct subsets of cytokine-induced killer (CIK) cells: implications for their infusion across major HLA barriersDario Sangiolo, Emanuela Martinuzzi, Maja Todorovic, et al.
Annals of Clinical and Translational Neurology|October 8, 2025
Interleukin-6 as a Key Biomarker in Facioscapulohumeral Dystrophy: Evidence From Longitudinal AnalysesJonathan Pini, Emanuela Martinuzzi, Sandra Dhifallah, et al.
Viruses|March 26, 2022
Low T Cell Responsiveness in the Early Phase of COVID-19 Associates with Progression to Severe Pneumonia in Kidney Transplant RecipientsMarion Cremoni, Sébastien Cuozzo, Emanuela Martinuzzi, et al.
Neuro-Oncology|May 18, 2012
Three sensitive assays do not provide evidence for circulating HuD-specific T cells in the blood of patients with paraneoplastic neurological syndromes with anti-Hu antibodiesAdriaan H C de Jongste, Marieke T de Graaf, Emanuela Martinuzzi, et al.
Pageof 3